Food and Drug Administration Open Meeting on Moderna COVID-19 Vaccine, Part 1
The FDA held a day-long meeting on Emergency Use Authorization (EUA) for Moderna’s COVID-19 vaccine. Presentations from the FDA and Moderna … read more
The FDA held a day-long meeting on Emergency Use Authorization (EUA) for Moderna’s COVID-19 vaccine. Presentations from the FDA and Moderna addressed issues such as allergic reactions and Bell’s Palsy that occurred with the recently approved Pfizer vaccine. The board also considered how to address ethical issues related to vaccine trial participants as approved vaccines become available. This was part one of a two-part meeting. close
People in this video
- Lindsey Baden M.D. Physician Brigham and Women's Hospital->Infectious Disease
- Amanda Cohn Executive Secretary Advisory Committee on Immunization Practices
- Marion Gruber Director U.S. Food and Drug Administration->Office of Vaccine Research and Review
- James Hildreth M.D. President and CEO Meharry Medical College
- Jeannette Lee Professor University of Arkansas->Biostatistics
- David Martin M.D. Vice President Moderna->Pharmacovigilance
- Jacqueline Miller M.D. Senior Vice President Moderna->Infectious Disease Therapeutics
- Melissa Moore M.D. Chief Scientific Officer Moderna->Platform Research
- James Neaton Professor University of Minnesota->Biostatistics
- Robert Schooley M.D. Professor University of California, San Diego->School of Medicine
- Gregg Sylvester M.D. Chief Medical Officer Seqirus->Medical Affairs
- Tal Zaks M.D. Chief Medical Officer Moderna
-
Doran Fink Deputy Director U.S. Food and Drug Administration->Vaccines and Related Biological Products Advisory Committee
-
Peter W. Marks M.D. Director U.S. Food and Drug Administration->Center for Biologics Evaluation and Research
-
Pamela McInnes Director National Institutes of Health->National Center for Advancing Translational Sciences
Hosting Organization
More Videos From
FDA Advisory Committee Votes 20-0 to Recommend Moderna COVID-19 Vaccine
Related Video
-
FDA Open Meeting on Moderna COVID-19 Vaccine, Part 2
The Food and Drug Administration held a virtual open meeting to discuss Moderna’s COVID-19 vaccine and whether it should…
-
Open Phones, Part 1
Viewers reacted to the Food and Drug Administration (FDA) giving the green light to the Pfizer vaccine to help curb the …
-
FDA Meeting on COVID-19 Vaccine and Emergency Use Authorization, Part 1
The Food and Drug Administration hosted a virtual open meeting to discuss Pfizer-BioNTech COVID-19 vaccine and Emergency…
-
FDA Open Meeting on Johnson & Johnson COVID-19 Vaccine, Part 1
The Food and Drug Administration (FDA) held a virtual open meeting to discuss emergency use authorization for the Johnso…